MD3284G2 - Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria - Google Patents

Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Info

Publication number
MD3284G2
MD3284G2 MDA20060148A MD20060148A MD3284G2 MD 3284 G2 MD3284 G2 MD 3284G2 MD A20060148 A MDA20060148 A MD A20060148A MD 20060148 A MD20060148 A MD 20060148A MD 3284 G2 MD3284 G2 MD 3284G2
Authority
MD
Moldova
Prior art keywords
treatment
atopic dermatitis
allergic rhinitis
chronic recurrent
recurrent urticaria
Prior art date
Application number
MDA20060148A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3284F1 (en
Inventor
Вера ОНУ
Аурел ГЫРБЯ
Алла ДЕРБЕНЦЕВА
Ион АБАБИЙ
Владимир ПОПА
Original Assignee
Аурел ГЫРБЯ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аурел ГЫРБЯ filed Critical Аурел ГЫРБЯ
Priority to MDA20060148A priority Critical patent/MD3284G2/en
Publication of MD3284F1 publication Critical patent/MD3284F1/en
Publication of MD3284G2 publication Critical patent/MD3284G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention refers to medicine, namely to therapy, dermatology, otorhinolaryngology and allergology.The method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria, according to the invention, consists in that it is carried out the endonasal electrophoresis with 1% cetirizine solution once a day during 12…15 days and there are administered H1-antihistaminic substances of first generation in the therapeutic dose during the first 5…7 days of treatment per os before going to bed.
MDA20060148A 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria MD3284G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060148A MD3284G2 (en) 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060148A MD3284G2 (en) 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Publications (2)

Publication Number Publication Date
MD3284F1 MD3284F1 (en) 2007-04-30
MD3284G2 true MD3284G2 (en) 2007-11-30

Family

ID=38164582

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060148A MD3284G2 (en) 2006-05-30 2006-05-30 Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria

Country Status (1)

Country Link
MD (1) MD3284G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2494774C1 (en) * 2012-09-12 2013-10-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Method of treating allergic rhinitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Клиническая аллергология. Под ред. акад. РАМН, проф. Р.М. Хаитова. Москва, Медпресс, 2002, с. 221-227, 334-342, 354-359 *

Also Published As

Publication number Publication date
MD3284F1 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
WO2008080062A3 (en) Equine airway disorders
WO2009086072A3 (en) Therapy of rituximab-refractory rheumatoid arthritis patients
HK1089378A1 (en) Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
MX2007003505A (en) Combination comprising zd6474 and an imatinib.
ATE500832T1 (en) COMBINATION OF ZD6474 AND PEMETREXED
BR112014018485A8 (en) USE OF LAQUINIMOD TO TREAT PATIENTS WITH CROHN'S DISEASE WHO HAVE FAILED FIRST LINE ANTI-TNF THERAPY
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
CY1111482T1 (en) COMBINATION AZD2171 AND PERMETRAXED
SE0400184D0 (en) New therapeutic use
NO20056170L (en) Cancer combination therapy comprising AZD2171 or ZD1839
NO20064755L (en) combination therapy
MX2010006724A (en) Therapeutic regimens for the treatment of immunoinflammatory disorders.
NO20064754L (en) combination therapy
MD3284G2 (en) Method of treatment of allergic rhinitis, atopic dermatitis and chronic recurrent urticaria
GB0405381D0 (en) A method and means for treating heart failure
UA97144C2 (en) Therapeutic plaster for trigger and acupuncture points and for meridian therapy
WO2008133952A3 (en) Transmucosal treatment with fentanyl in patients with mucositis
UA79796U (en) Method for treating postoperative abdominal abscess
MD10Z (en) Method for treating the gestational pyelonephritis

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees